Brief: 2Curex Provides Update Regarding The Covid-19 Impact On Ongoing Clinical Programs

2cureX AB

23/03/2020 07:46

March 23 (Reuters) - 2cureX AB  2CUREX.ST :
    * 2CUREX PROVIDES UPDATE REGARDING THE COVID-19 IMPACT ON ONGOING CLINICAL PROGRAMS
    * 2CUREX AB - CORONA-CRISIS WILL NOT DELAY 2CUREX'S INTERVENTION STUDY WHERE INDITREAT TEST
IS
GUIDING TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    * 2CUREX AB - PATIENT RECRUITMENT WILL CONTINUE AS PLANNED AND FINALIZATION OF TRIAL IS
EXPECTED
AS PREVIOUSLY COMMUNICATED IN Q3 OF 2020.
    * 2CUREX AB - LATER STARTED 2CUREX CLINICAL PROGRAMS IN OVARIAN CANCER AND PANCREATIC CANCER
WILL
HOWEVER BE AFFECTED BY DELAYS
    * 2CUREX AB - LENGTH OF THESE DELAYS IS NOT KNOWN PRESENTLY.

Source text for Eikon:  ID:nWkr1Rxyy7 
Further company coverage:  2CUREX.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))